Background: AIOD (Aorto-Iliac Occlusive Disease) may affect any of the arteries from the distal aorta to the common femoral arteries. CERAB (Covered Endovascular Reconstruction of Aortic Bifurcation) is a minimally invasive method used to treat significant and/or recurring aortoiliac occlusive disease. Bare-Metal stents are both effective and safe for treating AIOD. Bare-Metal stents had a statistically substantial greater risk of primary patency in both the general cohort and more complicated TASC C/D lesions. Methods: This was a comparative study done in Helwan University Hospital, Wadi Elnil Hospital, Shebin EL Kom teaching hospital and Aswan University Hospital from June 2020 to June 2022. The study was conducted on 45 subjects. Our study included 45 patients who were categorized into three groups in 1:1:1 ratio. Groups were covered stents, Endovascular Aneurysm Repair (EVAR), and Bare-Metal groups. Patients were followed clinically and by duplex US scan. Results:  There was no substantial variation among the three groups except in double barrel technique, Superficial Femoral Artery (SFA) angioplasty and complications occurrence. Double barrel was mostly used in Bare-Metal group, SFA angioplasty was significantly observed in Covered Stents group and complications frequently occurred in Bare-Metal group. Bare-Metal group re-intervention was significantly increased compared to other groups (Less patency). Conclusion:  A covered Stents and EVAR technique has proven to be optimal endovascular treatment options for aorto-iliac occlusive disease and is related to promising clinical outcomes. EVAR is more used with aneurysm occurrence. Through-out time Bare-Metal Stents have low patency rate compared to CERAB and EVAR techniques.